nodes	percent_of_prediction	percent_of_DWPC	metapath
Glucosamine—MMP9—bile duct cancer	0.884	1	CbGaD
Glucosamine—IFNG—pancreas—bile duct cancer	0.00229	0.161	CbGeAlD
Glucosamine—NFKB2—liver—bile duct cancer	0.00215	0.152	CbGeAlD
Glucosamine—TNF—lymph node—bile duct cancer	0.00167	0.118	CbGeAlD
Glucosamine—NFKB2—lymph node—bile duct cancer	0.00164	0.116	CbGeAlD
Glucosamine—MMP9—pancreas—bile duct cancer	0.00147	0.104	CbGeAlD
Glucosamine—IFNG—liver—bile duct cancer	0.00145	0.103	CbGeAlD
Glucosamine—IFNG—lymph node—bile duct cancer	0.00111	0.0788	CbGeAlD
Glucosamine—MMP9—liver—bile duct cancer	0.000934	0.066	CbGeAlD
Glucosamine—MMP9—lymph node—bile duct cancer	0.000716	0.0506	CbGeAlD
Glucosamine—IFNG—Downstream signaling in naïve CD8+ T cells—NRAS—bile duct cancer	0.000463	0.00454	CbGpPWpGaD
Glucosamine—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—bile duct cancer	0.000459	0.0045	CbGpPWpGaD
Glucosamine—TNF—Matrix Metalloproteinases—MMP9—bile duct cancer	0.000455	0.00446	CbGpPWpGaD
Glucosamine—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—bile duct cancer	0.000451	0.00442	CbGpPWpGaD
Glucosamine—MMP9—Plasma membrane estrogen receptor signaling—KRAS—bile duct cancer	0.000442	0.00433	CbGpPWpGaD
Glucosamine—IFNG—SHP2 signaling—KRAS—bile duct cancer	0.000442	0.00433	CbGpPWpGaD
Glucosamine—MMP9—amb2 Integrin signaling—IL6—bile duct cancer	0.000439	0.00429	CbGpPWpGaD
Glucosamine—NFKB2—TNF alpha Signaling Pathway—NRAS—bile duct cancer	0.000438	0.00429	CbGpPWpGaD
Glucosamine—NFKB2—Folate Metabolism—TP53—bile duct cancer	0.000437	0.00428	CbGpPWpGaD
Glucosamine—TNF—amb2 Integrin signaling—MMP9—bile duct cancer	0.000432	0.00423	CbGpPWpGaD
Glucosamine—TNF—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—bile duct cancer	0.000421	0.00412	CbGpPWpGaD
Glucosamine—TNF—IL27-mediated signaling events—TGFB1—bile duct cancer	0.000421	0.00412	CbGpPWpGaD
Glucosamine—IFNG—Regulation of Telomerase—TGFB1—bile duct cancer	0.00042	0.00411	CbGpPWpGaD
Glucosamine—MMP9—Extracellular matrix organization—TNC—bile duct cancer	0.000419	0.00411	CbGpPWpGaD
Glucosamine—CYP2C19—liver—bile duct cancer	0.000419	0.0296	CbGeAlD
Glucosamine—MMP9—Degradation of the extracellular matrix—MMP2—bile duct cancer	0.000415	0.00406	CbGpPWpGaD
Glucosamine—IFNG—Regulation of Telomerase—EGFR—bile duct cancer	0.000412	0.00403	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—TGFB1—bile duct cancer	0.000411	0.00402	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—HGF—bile duct cancer	0.00041	0.00402	CbGpPWpGaD
Glucosamine—TNF—Cytokines and Inflammatory Response—TGFB1—bile duct cancer	0.000408	0.004	CbGpPWpGaD
Glucosamine—TNF—Overview of nanoparticle effects—IL6—bile duct cancer	0.000408	0.00399	CbGpPWpGaD
Glucosamine—TNF—Angiopoietin receptor Tie2-mediated signaling—MMP2—bile duct cancer	0.000403	0.00394	CbGpPWpGaD
Glucosamine—NFKB2—Folate Metabolism—IL6—bile duct cancer	0.0004	0.00392	CbGpPWpGaD
Glucosamine—IFNG—Downstream signaling in naïve CD8+ T cells—KRAS—bile duct cancer	0.000399	0.0039	CbGpPWpGaD
Glucosamine—IFNG—Vitamin B12 Metabolism—IL6—bile duct cancer	0.000399	0.0039	CbGpPWpGaD
Glucosamine—IFNG—TGF-beta Receptor Signaling—HRAS—bile duct cancer	0.000398	0.0039	CbGpPWpGaD
Glucosamine—IFNG—IL2-mediated signaling events—HRAS—bile duct cancer	0.000398	0.0039	CbGpPWpGaD
Glucosamine—MMP9—EPH-Ephrin signaling—MMP2—bile duct cancer	0.000397	0.00389	CbGpPWpGaD
Glucosamine—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—bile duct cancer	0.000391	0.00382	CbGpPWpGaD
Glucosamine—NFKB2—Signaling by Interleukins—NRAS—bile duct cancer	0.000386	0.00377	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—NOS2—bile duct cancer	0.000385	0.00377	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—NRAS—bile duct cancer	0.000383	0.00375	CbGpPWpGaD
Glucosamine—NFKB2—TNF alpha Signaling Pathway—KRAS—bile duct cancer	0.000377	0.00369	CbGpPWpGaD
Glucosamine—MMP9—Plasma membrane estrogen receptor signaling—HRAS—bile duct cancer	0.000376	0.00368	CbGpPWpGaD
Glucosamine—IFNG—SHP2 signaling—HRAS—bile duct cancer	0.000376	0.00368	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—PTGS2—bile duct cancer	0.000374	0.00366	CbGpPWpGaD
Glucosamine—IFNG—Allograft Rejection—TGFB1—bile duct cancer	0.000373	0.00365	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—PTGS2—bile duct cancer	0.000369	0.00361	CbGpPWpGaD
Glucosamine—TNF—Transcription factor regulation in adipogenesis—IL6—bile duct cancer	0.000362	0.00355	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—ROBO2—bile duct cancer	0.000362	0.00354	CbGpPWpGaD
Glucosamine—NFKB2—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—bile duct cancer	0.000361	0.00354	CbGpPWpGaD
Glucosamine—IFNG—SHP2 signaling—IL6—bile duct cancer	0.00036	0.00352	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—TGFB1—bile duct cancer	0.000356	0.00348	CbGpPWpGaD
Glucosamine—IFNG—ATF-2 transcription factor network—IL6—bile duct cancer	0.000355	0.00347	CbGpPWpGaD
Glucosamine—IFNG—Folate Metabolism—TP53—bile duct cancer	0.000354	0.00347	CbGpPWpGaD
Glucosamine—MMP9—TWEAK Signaling Pathway—IL6—bile duct cancer	0.000353	0.00346	CbGpPWpGaD
Glucosamine—TNF—TWEAK Signaling Pathway—MMP9—bile duct cancer	0.000348	0.00341	CbGpPWpGaD
Glucosamine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—bile duct cancer	0.000345	0.00338	CbGpPWpGaD
Glucosamine—IFNG—Downstream signaling in naïve CD8+ T cells—HRAS—bile duct cancer	0.000339	0.00332	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—TP53—bile duct cancer	0.000338	0.00331	CbGpPWpGaD
Glucosamine—MMP9—Endochondral Ossification—TGFB1—bile duct cancer	0.000334	0.00327	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—HGF—bile duct cancer	0.000332	0.00325	CbGpPWpGaD
Glucosamine—NFKB2—Signaling by Interleukins—KRAS—bile duct cancer	0.000332	0.00325	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—KRAS—bile duct cancer	0.000329	0.00323	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—MMP9—bile duct cancer	0.000328	0.00321	CbGpPWpGaD
Glucosamine—MMP9—LPA receptor mediated events—EGFR—bile duct cancer	0.000328	0.00321	CbGpPWpGaD
Glucosamine—NFKB2—MyD88 cascade initiated on plasma membrane—IL6—bile duct cancer	0.000327	0.0032	CbGpPWpGaD
Glucosamine—IFNG—Folate Metabolism—IL6—bile duct cancer	0.000324	0.00318	CbGpPWpGaD
Glucosamine—NFKB2—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—bile duct cancer	0.000324	0.00317	CbGpPWpGaD
Glucosamine—NFKB2—TNF alpha Signaling Pathway—HRAS—bile duct cancer	0.000321	0.00314	CbGpPWpGaD
Glucosamine—MMP9—AGE/RAGE pathway—EGFR—bile duct cancer	0.00032	0.00313	CbGpPWpGaD
Glucosamine—NFKB2—MyD88 dependent cascade initiated on endosome—IL6—bile duct cancer	0.000318	0.00311	CbGpPWpGaD
Glucosamine—NFKB2—Selenium Micronutrient Network—IL6—bile duct cancer	0.000318	0.00311	CbGpPWpGaD
Glucosamine—TNF—IL27-mediated signaling events—IL6—bile duct cancer	0.000317	0.0031	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—TGFB1—bile duct cancer	0.000311	0.00305	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—IL6—bile duct cancer	0.000309	0.00303	CbGpPWpGaD
Glucosamine—TNF—Cytokines and Inflammatory Response—IL6—bile duct cancer	0.000308	0.00301	CbGpPWpGaD
Glucosamine—CYP2E1—liver—bile duct cancer	0.000308	0.0217	CbGeAlD
Glucosamine—NFKB2—TNF alpha Signaling Pathway—IL6—bile duct cancer	0.000307	0.003	CbGpPWpGaD
Glucosamine—NFKB2—Toll Like Receptor 9 (TLR9) Cascade—IL6—bile duct cancer	0.000307	0.003	CbGpPWpGaD
Glucosamine—NFKB2—MyD88:Mal cascade initiated on plasma membrane—IL6—bile duct cancer	0.000302	0.00295	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—TP53—bile duct cancer	0.000298	0.00292	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—TGFB1—bile duct cancer	0.000297	0.00291	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—TP53—bile duct cancer	0.000293	0.00287	CbGpPWpGaD
Glucosamine—NFKB2—MyD88-independent cascade—IL6—bile duct cancer	0.000289	0.00283	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—NRAS—bile duct cancer	0.000287	0.00281	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—PTGS2—bile duct cancer	0.000283	0.00278	CbGpPWpGaD
Glucosamine—NFKB2—Toll-like Receptor Signaling Pathway—IL6—bile duct cancer	0.000283	0.00277	CbGpPWpGaD
Glucosamine—NFKB2—Signaling by Interleukins—HRAS—bile duct cancer	0.000282	0.00276	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—HRAS—bile duct cancer	0.00028	0.00274	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—IL6—bile duct cancer	0.000273	0.00267	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—TGFB1—bile duct cancer	0.00027	0.00265	CbGpPWpGaD
Glucosamine—NFKB2—Signaling by Interleukins—IL6—bile duct cancer	0.00027	0.00264	CbGpPWpGaD
Glucosamine—TNF—amb2 Integrin signaling—IL6—bile duct cancer	0.000269	0.00263	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor Pathway—TGFB1—bile duct cancer	0.000267	0.00261	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—EGFR—bile duct cancer	0.000265	0.0026	CbGpPWpGaD
Glucosamine—MMP9—LPA receptor mediated events—HRAS—bile duct cancer	0.000263	0.00258	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor Pathway—EGFR—bile duct cancer	0.000261	0.00256	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—EGFR—bile duct cancer	0.000261	0.00256	CbGpPWpGaD
Glucosamine—NFKB2—Activated TLR4 signalling—IL6—bile duct cancer	0.00026	0.00255	CbGpPWpGaD
Glucosamine—IFNG—Selenium Micronutrient Network—IL6—bile duct cancer	0.000258	0.00252	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—TP53—bile duct cancer	0.000256	0.00251	CbGpPWpGaD
Glucosamine—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—bile duct cancer	0.000256	0.0025	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—TGFBR2—bile duct cancer	0.000253	0.00247	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—ERBB2—bile duct cancer	0.000251	0.00246	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—KRAS—bile duct cancer	0.000247	0.00242	CbGpPWpGaD
Glucosamine—NFKB2—Toll Like Receptor 4 (TLR4) Cascade—IL6—bile duct cancer	0.000245	0.0024	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—TP53—bile duct cancer	0.000244	0.00239	CbGpPWpGaD
Glucosamine—TNF—IL23-mediated signaling events—IL6—bile duct cancer	0.000239	0.00234	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—NOS2—bile duct cancer	0.000236	0.00231	CbGpPWpGaD
Glucosamine—TNF—TGF-beta Receptor Signaling—TGFB1—bile duct cancer	0.000235	0.0023	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—IL6—bile duct cancer	0.000235	0.0023	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—HRAS—bile duct cancer	0.000234	0.00229	CbGpPWpGaD
Glucosamine—MMP9—Validated targets of C-MYC transcriptional activation—TP53—bile duct cancer	0.000233	0.00228	CbGpPWpGaD
Glucosamine—TNF—Cardiac Hypertrophic Response—TGFB1—bile duct cancer	0.000231	0.00226	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—IL6—bile duct cancer	0.000224	0.00219	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—TP53—bile duct cancer	0.000223	0.00218	CbGpPWpGaD
Glucosamine—NFKB2—Regulation of toll-like receptor signaling pathway—IL6—bile duct cancer	0.000221	0.00216	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—PTGS2—bile duct cancer	0.000219	0.00215	CbGpPWpGaD
Glucosamine—NFKB2—Toll-Like Receptors Cascades—IL6—bile duct cancer	0.000218	0.00214	CbGpPWpGaD
Glucosamine—TNF—TWEAK Signaling Pathway—IL6—bile duct cancer	0.000216	0.00212	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	0.000216	0.00211	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—NRAS—bile duct cancer	0.000215	0.0021	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	0.00021	0.00206	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—TGFB1—bile duct cancer	0.000205	0.00201	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—IL6—bile duct cancer	0.000204	0.002	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—IL6—bile duct cancer	0.000201	0.00197	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—EGFR—bile duct cancer	0.000201	0.00197	CbGpPWpGaD
Glucosamine—MMP9—EPH-Ephrin signaling—HRAS—bile duct cancer	0.000194	0.00189	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.000192	0.00188	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—NRAS—bile duct cancer	0.000191	0.00187	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—KRAS—bile duct cancer	0.000185	0.00181	CbGpPWpGaD
Glucosamine—TNF—Vitamin B12 Metabolism—IL6—bile duct cancer	0.000185	0.00181	CbGpPWpGaD
Glucosamine—TNF—TGF-beta Receptor Signaling—HRAS—bile duct cancer	0.000185	0.00181	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—NRAS—bile duct cancer	0.00018	0.00176	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—MET—bile duct cancer	0.000177	0.00173	CbGpPWpGaD
Glucosamine—TNF—Transcriptional regulation of white adipocyte differentiation—TGFB1—bile duct cancer	0.000177	0.00173	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—EGFR—bile duct cancer	0.000174	0.00171	CbGpPWpGaD
Glucosamine—MMP9—Extracellular matrix organization—MMP2—bile duct cancer	0.000174	0.0017	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—PTGS2—bile duct cancer	0.000174	0.0017	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—TGFB1—bile duct cancer	0.000173	0.00169	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—TP53—bile duct cancer	0.000169	0.00165	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—NRAS—bile duct cancer	0.000165	0.00161	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—SMAD4—bile duct cancer	0.000165	0.00161	CbGpPWpGaD
Glucosamine—TNF—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—bile duct cancer	0.000165	0.00161	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—KRAS—bile duct cancer	0.000165	0.00161	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—TP53—bile duct cancer	0.000164	0.00161	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—HRAS—bile duct cancer	0.000157	0.00154	CbGpPWpGaD
Glucosamine—CYP2C19—Arachidonic acid metabolism—PTGS2—bile duct cancer	0.000155	0.00152	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—KRAS—bile duct cancer	0.000155	0.00152	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—IL6—bile duct cancer	0.000154	0.00151	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—MMP9—bile duct cancer	0.000152	0.00149	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—IL6—bile duct cancer	0.00015	0.00147	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—MMP2—bile duct cancer	0.000147	0.00144	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—NRAS—bile duct cancer	0.000146	0.00143	CbGpPWpGaD
Glucosamine—TNF—Alzheimers Disease—TP53—bile duct cancer	0.000142	0.00139	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—KRAS—bile duct cancer	0.000142	0.00139	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—HRAS—bile duct cancer	0.00014	0.00137	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—bile duct cancer	0.000136	0.00133	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HGF—bile duct cancer	0.000134	0.00131	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—IL6—bile duct cancer	0.000134	0.00131	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—ERBB2—bile duct cancer	0.000133	0.0013	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—HRAS—bile duct cancer	0.000132	0.00129	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—ERBB2—bile duct cancer	0.000129	0.00127	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—RNF43—bile duct cancer	0.000127	0.00124	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—MET—bile duct cancer	0.000126	0.00124	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—IL6—bile duct cancer	0.000126	0.00123	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—TGFB1—bile duct cancer	0.000125	0.00123	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—KRAS—bile duct cancer	0.000125	0.00123	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—EGFR—bile duct cancer	0.000123	0.0012	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	0.000121	0.00118	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—HRAS—bile duct cancer	0.000121	0.00118	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—IL6—bile duct cancer	0.00012	0.00117	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	0.000118	0.00116	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—TGFB1—bile duct cancer	0.000116	0.00114	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—IL6—bile duct cancer	0.000115	0.00113	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—FAR2—bile duct cancer	0.000111	0.00108	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HGF—bile duct cancer	0.000109	0.00106	CbGpPWpGaD
Glucosamine—MMP9—Extracellular matrix organization—TGFB1—bile duct cancer	0.000108	0.00105	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—HRAS—bile duct cancer	0.000107	0.00104	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—IL6—bile duct cancer	0.000106	0.00104	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—MMP2—bile duct cancer	0.000105	0.00103	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—TP53—bile duct cancer	0.000103	0.00101	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—IL6—bile duct cancer	0.000102	0.000999	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—NRAS—bile duct cancer	0.000102	0.000997	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—NRAS—bile duct cancer	0.000101	0.000988	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—SMAD4—bile duct cancer	0.000101	0.000988	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—NRAS—bile duct cancer	9.83e-05	0.000962	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—TGFB1—bile duct cancer	9.46e-05	0.000926	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—IL6—bile duct cancer	9.46e-05	0.000926	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—EGFR—bile duct cancer	9.27e-05	0.000908	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—ERBB2—bile duct cancer	9.22e-05	0.000903	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—EGFR—bile duct cancer	9.19e-05	0.0009	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—EGFR—bile duct cancer	8.96e-05	0.000877	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—KRAS—bile duct cancer	8.76e-05	0.000858	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—IL6—bile duct cancer	8.75e-05	0.000857	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—KRAS—bile duct cancer	8.68e-05	0.00085	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	8.54e-05	0.000836	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—FAR2—bile duct cancer	8.53e-05	0.000835	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—KRAS—bile duct cancer	8.46e-05	0.000828	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	8.37e-05	0.000819	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—bile duct cancer	8.3e-05	0.000813	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—IL6—bile duct cancer	8.29e-05	0.000812	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	8.04e-05	0.000788	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	7.91e-05	0.000774	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—TP53—bile duct cancer	7.79e-05	0.000762	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—ERBB2—bile duct cancer	7.72e-05	0.000756	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—MET—bile duct cancer	7.72e-05	0.000756	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—IL6—bile duct cancer	7.56e-05	0.00074	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—HRAS—bile duct cancer	7.38e-05	0.000723	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—HRAS—bile duct cancer	7.19e-05	0.000704	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—IL6—bile duct cancer	7.06e-05	0.000692	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	7.03e-05	0.000688	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—NRAS—bile duct cancer	7.01e-05	0.000687	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—IL6—bile duct cancer	6.88e-05	0.000674	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—TGFB1—bile duct cancer	6.52e-05	0.000638	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—MMP2—bile duct cancer	6.44e-05	0.000631	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—EGFR—bile duct cancer	6.39e-05	0.000626	CbGpPWpGaD
Glucosamine—IFNG—Immune System—ERBB2—bile duct cancer	6.26e-05	0.000613	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—KRAS—bile duct cancer	6.04e-05	0.000591	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—NRAS—bile duct cancer	5.88e-05	0.000575	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TGFBR2—bile duct cancer	5.79e-05	0.000567	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—ERBB2—bile duct cancer	5.65e-05	0.000553	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—GNAS—bile duct cancer	5.58e-05	0.000547	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SMAD4—bile duct cancer	5.48e-05	0.000536	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—IDH2—bile duct cancer	5.4e-05	0.000529	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—EGFR—bile duct cancer	5.35e-05	0.000524	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—HRAS—bile duct cancer	5.13e-05	0.000502	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—KRAS—bile duct cancer	5.06e-05	0.000495	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—IL6—bile duct cancer	4.91e-05	0.000481	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—MMP9—bile duct cancer	4.84e-05	0.000474	CbGpPWpGaD
Glucosamine—IFNG—Immune System—NRAS—bile duct cancer	4.76e-05	0.000466	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—IDH1—bile duct cancer	4.64e-05	0.000455	CbGpPWpGaD
Glucosamine—IFNG—Immune System—EGFR—bile duct cancer	4.34e-05	0.000425	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HRAS—bile duct cancer	4.3e-05	0.000421	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—NRAS—bile duct cancer	4.3e-05	0.000421	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—IDH2—bile duct cancer	4.17e-05	0.000408	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL6—bile duct cancer	4.11e-05	0.000403	CbGpPWpGaD
Glucosamine—IFNG—Immune System—KRAS—bile duct cancer	4.1e-05	0.000401	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—TGFB1—bile duct cancer	3.99e-05	0.000391	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—EGFR—bile duct cancer	3.91e-05	0.000383	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—KRAS—bile duct cancer	3.7e-05	0.000362	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—IDH1—bile duct cancer	3.58e-05	0.000351	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HRAS—bile duct cancer	3.48e-05	0.000341	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL6—bile duct cancer	3.33e-05	0.000326	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—HRAS—bile duct cancer	3.14e-05	0.000308	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—ERBB2—bile duct cancer	3.07e-05	0.0003	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—SLC5A5—bile duct cancer	3.06e-05	0.0003	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—IL6—bile duct cancer	3.01e-05	0.000294	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GNAS—bile duct cancer	2.38e-05	0.000233	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—SLC5A5—bile duct cancer	2.36e-05	0.000231	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NRAS—bile duct cancer	2.33e-05	0.000228	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	2.21e-05	0.000217	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TGFB1—bile duct cancer	2.17e-05	0.000212	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—EGFR—bile duct cancer	2.13e-05	0.000208	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—KRAS—bile duct cancer	2.01e-05	0.000197	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GNAS—bile duct cancer	1.84e-05	0.00018	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TP53—bile duct cancer	1.78e-05	0.000175	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—HRAS—bile duct cancer	1.71e-05	0.000167	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IL6—bile duct cancer	1.63e-05	0.00016	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PTGS2—bile duct cancer	1.28e-05	0.000125	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PTGS2—bile duct cancer	9.86e-06	9.66e-05	CbGpPWpGaD
